Abstract:Osteoarthritic degeneration of cartilage is a major social health problem. Tissue engineering of cartilage using combinations of scaffold and mesenchymal stem cells (MSCs) is emerging as an alternative to existing treatment options such as microfracture, mosaicplasty, allograft, autologous chondrocyte implantation, or total joint replacement. Induction of chondrogenesis in high-density pellets of MSCs is generally attained by soluble exogenous TGF-β3 in culture media, which requires lengthy in vitro culture period during which pellets gain mechanical robustness. On the other hand, a growth factor delivering and a mechanically robust scaffold material that can accommodate chondroid pellets would enable rapid deployment of pellets after seeding. Delivery of the growth factor from the scaffold locally would drive the induction of chondrogenic differentiation in the postimplantation period. Therefore, we sought to develop a biomaterial formulation that will induce chondrogenesis in situ, and compared its performance to soluble delivery in vitro. In this vein, a heparin-conjugated mechanically robust collagen fabric was developed for sustained delivery of TGF-β3. The amount of conjugated heparin was varied to enhance the amount of TGF-β3 uptake and release from the scaffold. The results showed that the scaffold delivered TGF-β3 for up to 8 days of culture, which resulted in 15-fold increase in GAG production, and six-fold increase in collagen synthesis with respect to the No TGF-β3 group. The resulting matrix was cartilage like, in that type II collagen and aggrecan were positive in the spheroids. Enhanced chondrogenesis under in situ TGF-β3 administration resulted in a Young's modulus of ∼600 kPa. In most metrics, there were no significant differences between the soluble delivery group and in situ heparin-mediated delivery group. In conclusion, heparin-conjugated collagen scaffold developed in this study guides chondrogenic differentiation of hMSCs in a mechanically competent tissue construct, which showed potential to be used for cartilage tissue regeneration. Impact statement The most significant finding of this study was that sustained release of TGF-β3 from heparinized collagen scaffold had chondroinductive effect on pelleted human mesenchymal stem cells (hMSCs). The effect was comparable to that observed in hMSC pellets that were cultured in chondrogenic media supplemented with TGF-β3. The stiffness of scaffolds at the baseline was about 50% that of native cartilage and over 28 days the combined stiffness of pellet/scaffold complex converged to the stiffness of native cartilage. These data indicate that the scaffold system can generate a load-bearing cartilage-like tissue by using hMSCs pellets in a mechanically competent framework.

Fabrication of Stem Cell Heterospheroids with Sustained-Release Chitosan and Poly(lactic-Co-glycolic Acid) Microspheres to Guide Cell Fate Toward Chondrogenic Differentiation.

Molecular and Cellular Characterization During Chondrogenic Differentiation of Adipose Tissue-Derived Stromal Cells in Vitro and Cartilage Formation in Vivo

Stem cell differentiation-related protein-loaded PLGA microspheres as a novel platform micro-typed scaffold for chondrogenesis

Fast Fabrication of Stable Cartilage-Like Tissue Using Collagen Hydrogel Microsphere Culture.

Dual Delivery for Stem Cell Differentiation Using Dexamethasone and Bfgf In/on Polymeric Microspheres As a Cell Carrier for Nucleus Pulposus Regeneration

A Chondrogenesis Induction System Based on a Functionalized Hyaluronic Acid Hydrogel Sequentially Promoting Hmsc Proliferation, Condensation, Differentiation, and Matrix Deposition.

Chondrogenic differentiation of human mesenchymal stem cells using a thermosensitive poly(N-isopropylacrylamide) and water-soluble chitosan copolymer

Chondrogenesis of Mesenchymal Stem Cells through Local Release of TGF-β3 from Heparinized Collagen Biofabric

Glucosamine-modified Polyethylene Glycol Hydrogel-Mediated Chondrogenic Differentiation of Human Mesenchymal Stem Cells.

Regulation of Human Mesenchymal Stem Cells Differentiation into Chondrocytes in Extracellular Matrix-Based Hydrogel Scaffolds

Pharmacological Modulation of Human Mesenchymal Stem Cell Chondrogenesis by a Chemically Oversulfated Polysaccharide of Marine Origin: Potential Application to Cartilage Regenerative Medicine

Chondrogenic differentiation of BMSCs encapsulated in chondroinductive polysaccharide/collagen hybrid hydrogels

Chondrogenic Commitment of Human Bone Marrow Mesenchymal Stem Cells in a Perfused Collagen Hydrogel Functionalized with hTGF-β1-Releasing PLGA Microcarrier

Nanocarrier‐Mediated Codelivery of Small Molecular Drugs and Sirna to Enhance Chondrogenic Differentiation and Suppress Hypertrophy of Human Mesenchymal Stem Cells

Directing Chondrogenic Differentiation of Mesenchymal Stem Cells with a Solid-Supported Chitosan Thermogel for Cartilage Tissue Engineering

Scalable and Uniform Fabrication of Dexamethasone-Eluting Depot-Engineered Stem Cell Spheroids As a Microtissue Construct to Target Bone Regeneration

Chondrogenesis of bone marrow mesenchymal stem cell in alginate microspheres

Microsphere-based drug releasing scaffolds for inducing osteogenesis of human mesenchymal stem cells in vitro.

Chondrogenesis of Synovium-Derived Mesenchymal Stem Cells in Photopolymerizing Hydrogel Scaffolds

A chondroitin sulfate based injectable hydrogel for delivery of stem cells in cartilage regeneration

Synthesis and Characterization of Polyphosphazene Microspheres Incorporating Demineralized Bone Matrix Scaffolds Controlled Release of Growth Factor for Chondrogenesis Applications